| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |